BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 23778523)

  • 21. Inhibition of MALT1 protease activity is selectively toxic for activated B cell-like diffuse large B cell lymphoma cells.
    Ferch U; Kloo B; Gewies A; Pfänder V; Düwel M; Peschel C; Krappmann D; Ruland J
    J Exp Med; 2009 Oct; 206(11):2313-20. PubMed ID: 19841089
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Bcl10/Malt1 signaling is essential for TCR-induced NF-kappaB activation in thymocytes but dispensable for positive or negative selection.
    Jost PJ; Weiss S; Ferch U; Gross O; Mak TW; Peschel C; Ruland J
    J Immunol; 2007 Jan; 178(2):953-60. PubMed ID: 17202357
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A role for MALT1 activity in Kaposi's sarcoma-associated herpes virus latency and growth of primary effusion lymphoma.
    Bonsignore L; Passelli K; Pelzer C; Perroud M; Konrad A; Thurau M; Stürzl M; Dai L; Trillo-Tinoco J; Del Valle L; Qin Z; Thome M
    Leukemia; 2017 Mar; 31(3):614-624. PubMed ID: 27538487
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Probes to monitor activity of the paracaspase MALT1.
    Hachmann J; Edgington-Mitchell LE; Poreba M; Sanman LE; Drag M; Bogyo M; Salvesen GS
    Chem Biol; 2015 Jan; 22(1):139-47. PubMed ID: 25556944
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The inhibitor of apoptosis protein fusion c-IAP2.MALT1 stimulates NF-kappaB activation independently of TRAF1 AND TRAF2.
    Varfolomeev E; Wayson SM; Dixit VM; Fairbrother WJ; Vucic D
    J Biol Chem; 2006 Sep; 281(39):29022-9. PubMed ID: 16891304
    [TBL] [Abstract][Full Text] [Related]  

  • 26. MALT1 is a potential therapeutic target in glioblastoma and plays a crucial role in EGFR-induced NF-κB activation.
    Liu X; Yue C; Shi L; Liu G; Cao Q; Shan Q; Wang Y; Chen X; Li H; Wang J; Gao S; Niu M; Yu R
    J Cell Mol Med; 2020 Jul; 24(13):7550-7562. PubMed ID: 32452133
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The paracaspase MALT1 is a downstream target of Smad3 and potentiates the crosstalk between TGF-β and NF-kB signaling pathways in cancer cells.
    Mazi FA; Cakiroglu E; Uysal M; Kalyoncu M; Demirci D; Sozeri PYG; Yilmaz GO; Ozhan SE; Senturk S
    Cell Signal; 2023 May; 105():110611. PubMed ID: 36708753
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Single nucleotide polymorphisms of mucosa-associated lymphoid tissue 1 in oral carcinoma cells and gingival fibroblasts.
    Oyama G; Midorikawa T; Matsumoto Y; Takeyama M; Yamada K; Nozawa T; Morikawa M; Imai K
    Odontology; 2013 Jul; 101(2):150-5. PubMed ID: 22752732
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The Paracaspase MALT1.
    Hachmann J; Salvesen GS
    Biochimie; 2016 Mar; 122():324-38. PubMed ID: 26386283
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The paracaspase MALT1 mediates CARD14-induced signaling in keratinocytes.
    Afonina IS; Van Nuffel E; Baudelet G; Driege Y; Kreike M; Staal J; Beyaert R
    EMBO Rep; 2016 Jun; 17(6):914-27. PubMed ID: 27113748
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A20 negatively regulates T cell receptor signaling to NF-kappaB by cleaving Malt1 ubiquitin chains.
    Düwel M; Welteke V; Oeckinghaus A; Baens M; Kloo B; Ferch U; Darnay BG; Ruland J; Marynen P; Krappmann D
    J Immunol; 2009 Jun; 182(12):7718-28. PubMed ID: 19494296
    [TBL] [Abstract][Full Text] [Related]  

  • 32. CXCL12/SDF-1 alpha activates NF-kappaB and promotes oral cancer invasion through the Carma3/Bcl10/Malt1 complex.
    Rehman AO; Wang CY
    Int J Oral Sci; 2009 Sep; 1(3):105-18. PubMed ID: 20695076
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pharmacologic inhibition of MALT1 protease by phenothiazines as a therapeutic approach for the treatment of aggressive ABC-DLBCL.
    Nagel D; Spranger S; Vincendeau M; Grau M; Raffegerst S; Kloo B; Hlahla D; Neuenschwander M; Peter von Kries J; Hadian K; Dörken B; Lenz P; Lenz G; Schendel DJ; Krappmann D
    Cancer Cell; 2012 Dec; 22(6):825-37. PubMed ID: 23238017
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Expression of MALT1 oncogene in hematopoietic stem/progenitor cells recapitulates the pathogenesis of human lymphoma in mice.
    Vicente-Dueñas C; Fontán L; Gonzalez-Herrero I; Romero-Camarero I; Segura V; Aznar MA; Alonso-Escudero E; Campos-Sanchez E; Ruiz-Roca L; Barajas-Diego M; Sagardoy A; Martinez-Ferrandis JI; Abollo-Jimenez F; Bertolo C; Peñuelas I; Garcia-Criado FJ; García-Cenador MB; Tousseyn T; Agirre X; Prosper F; Garcia-Bragado F; McPhail ED; Lossos IS; Du MQ; Flores T; Hernandez-Rivas JM; Gonzalez M; Salar A; Bellosillo B; Conde E; Siebert R; Sagaert X; Cobaleda C; Sanchez-Garcia I; Martinez-Climent JA
    Proc Natl Acad Sci U S A; 2012 Jun; 109(26):10534-9. PubMed ID: 22689981
    [TBL] [Abstract][Full Text] [Related]  

  • 35. CD109 acts as a gatekeeper of the epithelial trait by suppressing epithelial to mesenchymal transition in squamous cell carcinoma cells in vitro.
    Zhou S; da Silva SD; Siegel PM; Philip A
    Sci Rep; 2019 Nov; 9(1):16317. PubMed ID: 31695056
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A homozygous mucosa-associated lymphoid tissue 1 (MALT1) mutation in a family with combined immunodeficiency.
    Jabara HH; Ohsumi T; Chou J; Massaad MJ; Benson H; Megarbane A; Chouery E; Mikhael R; Gorka O; Gewies A; Portales P; Nakayama T; Hosokawa H; Revy P; Herrod H; Le Deist F; Lefranc G; Ruland J; Geha RS
    J Allergy Clin Immunol; 2013 Jul; 132(1):151-8. PubMed ID: 23727036
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Differential requirement for Malt1 in T and B cell antigen receptor signaling.
    Ruland J; Duncan GS; Wakeham A; Mak TW
    Immunity; 2003 Nov; 19(5):749-58. PubMed ID: 14614861
    [TBL] [Abstract][Full Text] [Related]  

  • 38. MALT1 protease: a new therapeutic target in B lymphoma and beyond?
    McAllister-Lucas LM; Baens M; Lucas PC
    Clin Cancer Res; 2011 Nov; 17(21):6623-31. PubMed ID: 21868762
    [TBL] [Abstract][Full Text] [Related]  

  • 39. MALT1--a universal soldier: multiple strategies to ensure NF-κB activation and target gene expression.
    Afonina IS; Elton L; Carpentier I; Beyaert R
    FEBS J; 2015 Sep; 282(17):3286-97. PubMed ID: 25996250
    [TBL] [Abstract][Full Text] [Related]  

  • 40. T-cell receptor-induced JNK activation requires proteolytic inactivation of CYLD by MALT1.
    Staal J; Driege Y; Bekaert T; Demeyer A; Muyllaert D; Van Damme P; Gevaert K; Beyaert R
    EMBO J; 2011 May; 30(9):1742-52. PubMed ID: 21448133
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.